Induction of antinuclear antibodies in patients with rheumatoid arthritis treated with infliximab and leflunomide.
Bingham
Sarah J
SJ
Leeds General Infirmary, Leeds, UK.
Buch
Maya H
MH
Kerr
Michael A
MA
Emery
Paul
P
Valadäo Barcelos
Anabela Tavares
AT
D000276:Adjuvants, Immunologic / Q000009:adverse effects*; D000974:Antibodies, Antinuclear / Q000276:immunology*; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000276:immunology; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000276:immunology; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000276:immunology; D004359:Drug Therapy, Combination; D006801:Humans; D000069285:Infliximab; D007555:Isoxazoles / Q000009:adverse effects* / Q000276:immunology; D000077339:Leflunomide
D000276:Adjuvants, Immunologic; D000974:Antibodies, Antinuclear; D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D007555:Isoxazoles; D000069285:Infliximab; D000077339:Leflunomide